Public Attitudes to Rare Diseases: The case for equal access

Influencing and shaping our sector | BIA update: January - April 2021

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from January to April 2021.

NICE Methods Review: BIA response to consultation on NICE processes of health technology evaluation

BIA submission to BEIS consultation on subsidy control.

The BIA has responded to a BEIS consultation on subsidy control.

BIA response to DEFRA's consultation on the regulation of genetic technologies

The BIA has responded the Department for Environment, Food and Rural Affairs (Defra) consultation on the regulation of genetic technologies.

The science of success

The Science of Success

BIA response to the Science and Technology Committee's inquiry on UK ARPA

The BIA has responded to the Science and Technology Committee’s inquiry on a UK Advanced Research Projects Agency (ARPA).

Influencing and shaping our sector | BIA update: October 2020 - January 2021

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2020 to January 2021.

BIA submission to the Lord Hill review of UK listing rules

The BIA has written to Lord Hill responding to his call for evidence on the UK's listing rules. 

BIA response to the National Security and Investment Bill